Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cancer subtype:

Thyroid cancer. Cabanillas ME et al. Lancet. (2016)

Back to the Colorectal Cancer Consensus Molecular Subtype Future. Menter DG et al. Curr Gastroenterol Rep. (2019)

Assessment of Breast Cancer Risk Factors Reveals Subtype Heterogeneity. Holm J et al. Cancer Res. (2017)

Search results

Items: 1 to 20 of 34684

1.

The immune microenvironment of uterine adenosarcomas.

Ali AMR, Tsai JW, Leung CH, Lin H, Ravi V, Conley AP, Lazar AJ, Wang WL, Nathenson MJ.

Clin Sarcoma Res. 2020 Mar 28;10:5. doi: 10.1186/s13569-020-0127-0. eCollection 2020.

2.

Prevalence and Genotyping of Cryptosporidium parvum in Gastrointestinal Cancer Patients.

Zhang N, Yu X, Zhang H, Cui L, Li X, Zhang X, Gong P, Li J, Li Z, Wang X, Li X, Li T, Liu X, Yu Y, Zhang X.

J Cancer. 2020 Mar 5;11(11):3334-3339. doi: 10.7150/jca.42393. eCollection 2020.

3.
4.

Male Breast Cancer: Surgical and Genetic Features and a Multidisciplinary Management Strategy.

Pellini F, Granuzzo E, Urbani S, Mirandola S, Caldana M, Lombardi D, Fiorio E, Mandarà M, Pollini GP.

Breast Care (Basel). 2020 Feb;15(1):14-20. doi: 10.1159/000501711. Epub 2019 Sep 13.

PMID:
32231493
5.

Transforming growth factor beta 1 (TGFβ1) plasmatic levels in breast cancer and neoplasia-free women: Association with patients' characteristics and TGFB1 haplotypes.

Vitiello GAF, Amarante MK, Oda JMM, Hirata BKB, de Oliveira CEC, Campos CZ, de Oliveira KB, Guembarovski RL, Watanabe MAE.

Cytokine. 2020 Mar 28;130:155079. doi: 10.1016/j.cyto.2020.155079. [Epub ahead of print]

PMID:
32229413
6.

Predictors of self-expanding metallic stent dysfunction in malignant gastric outlet obstruction.

Suder-Castro LS, Ramírez-Solís ME, Hernández-Guerrero AI, de la Mora-Levy JG, Alonso-Lárraga JO, Hernández-Lara AH.

Rev Gastroenterol Mex. 2020 Mar 27. pii: S0375-0906(20)30013-6. doi: 10.1016/j.rgmx.2019.07.009. [Epub ahead of print] English, Spanish.

PMID:
32229056
7.

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.

Reustle A, Di Marco M, Meyerhoff C, Nelde A, Walz JS, Winter S, Kandabarau S, Büttner F, Haag M, Backert L, Kowalewski DJ, Rausch S, Hennenlotter J, Stühler V, Scharpf M, Fend F, Stenzl A, Rammensee HG, Bedke J, Stevanović S, Schwab M, Schaeffeler E.

Genome Med. 2020 Mar 30;12(1):32. doi: 10.1186/s13073-020-00731-8.

8.

Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.

Liu Q, Yang C, Wang S, Shi D, Wei C, Song J, Lin X, Dou R, Bai J, Xiang Z, Huang S, Liu K, Xiong B.

Cell Commun Signal. 2020 Mar 30;18(1):51. doi: 10.1186/s12964-020-00557-2.

9.

New Machine Learning Applications to Accelerate Personalized Medicine in Breast Cancer: Rise of the Support Vector Machines.

Ozer ME, Sarica PO, Arga KY.

OMICS. 2020 Mar 31. doi: 10.1089/omi.2020.0001. [Epub ahead of print]

PMID:
32228365
10.

Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.

Mulé S, Galletto Pregliasco A, Tenenhaus A, Kharrat R, Amaddeo G, Baranes L, Laurent A, Regnault H, Sommacale D, Djabbari M, Pigneur F, Tacher V, Kobeiter H, Calderaro J, Luciani A.

Radiology. 2020 Mar 31:192230. doi: 10.1148/radiol.2020192230. [Epub ahead of print]

PMID:
32228294
11.

Role of MRI to Assess Response to Neoadjuvant Therapy for Breast Cancer.

Reig B, Heacock L, Lewin A, Cho N, Moy L.

J Magn Reson Imaging. 2020 Mar 29. doi: 10.1002/jmri.27145. [Epub ahead of print]

PMID:
32227407
12.

Metachronic Breast and Cerebellar Neoplasm in a Young Patient.

Nascimento JO, Haro LCA, Sá RDS, Storch RE.

Rev Bras Ginecol Obstet. 2020 Feb;42(2):114-119. doi: 10.1055/s-0040-1701456. Epub 2020 Mar 30.

13.

DCST1-AS1 Promotes TGF-β-Induced Epithelial-Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1.

Tang L, Chen Y, Chen H, Jiang P, Yan L, Mo D, Tang X, Yan F.

Front Oncol. 2020 Mar 12;10:280. doi: 10.3389/fonc.2020.00280. eCollection 2020.

14.

Macrophage-derived SPARC Attenuates M2-mediated Pro-tumour Phenotypes.

Hu J, Ma Y, Ma J, Chen S, Zhang X, Guo S, Huang Z, Yue T, Yang Y, Ning Y, Zhu J, Wang P, Wang X, Chen G, Liu Y.

J Cancer. 2020 Mar 4;11(10):2981-2992. doi: 10.7150/jca.39651. eCollection 2020.

15.

Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer.

Ren Q, Zhu P, Zhang H, Ye T, Liu D, Gong Z, Xia X.

Cancer Cell Int. 2020 Mar 24;20:92. doi: 10.1186/s12935-020-01173-3. eCollection 2020.

16.

PAIVS: prediction of avian influenza virus subtype.

Park HC, Shin J, Cho SM, Kang S, Chung YJ, Jung SH.

Genomics Inform. 2020 Mar;18(1):e5. doi: 10.5808/GI.2020.18.1.e5. Epub 2020 Mar 31.

17.

Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.

Shi F, He Y, Li J, Tang M, Li Y, Xie L, Zhao L, Hu J, Luo X, Zhou M, Liu N, Fan J, Zhou J, Gao Q, Qiu S, Wu W, Zhang X, Jia W, Bode AM, Cao Y.

Mol Metab. 2020 Feb 18;36:100966. doi: 10.1016/j.molmet.2020.02.009. [Epub ahead of print]

18.

Use of endoscopic assessment of gastric atrophy for gastric cancer risk stratification to reduce the need for gastric mapping.

Quach DT, Hiyama T, Le HM, Nguyen TS, Gotoda T.

Scand J Gastroenterol. 2020 Mar 28:1-6. doi: 10.1080/00365521.2020.1740777. [Epub ahead of print]

PMID:
32223458
19.

Everyday discrimination and telomere length in a multiethnic cohort of breast cancer survivors.

Aghaee S, Allen A, Ramirez J, Shariff-Marco S, Allen L, DeRouen M, Elmofty M, Marquez-Magana L, Gomez SL.

Ethn Health. 2020 Mar 28:1-12. doi: 10.1080/13557858.2020.1739231. [Epub ahead of print]

PMID:
32223329
20.

Molecular description of ANGPT2 associated colorectal carcinoma.

Jary M, Hasanova R, Vienot A, Asgarov K, Loyon R, Tirole C, Bouard A, Orillard E, Klajer E, Kim S, Viot J, Colle E, Adotevi O, Bouché O, Lecomte T, Borg C, Feugeas JP.

Int J Cancer. 2020 Mar 29. doi: 10.1002/ijc.32993. [Epub ahead of print]

PMID:
32222972

Supplemental Content

Loading ...
Support Center